4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-019792
Director sold 23,333 shares at $16.86 ($393,394)
- Director acquired 23,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hutson Nancy J · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-10 | Exercise or conversion : show line 1 in the form | +8,333 | $2.85 | $23,749 | 73,406 | D |
| 2021-06-10 | Exercise or conversion : show line 2 in the form | +15,000 | $3.32 | $49,800 | 88,406 | D |
| 2021-06-10 | Sale : show line 3 in the form | −23,333 | $16.86 | $393,394 | 65,073 | D |
| Open-market sales · 23,333 sh · avg $16.86 · $393,394 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-10 | Exercise or conversion : show line 4 in the form Non-Qualified Stock Option | −8,333 | 0 | D |
| 2021-06-10 | Exercise or conversion : show line 5 in the form Automatic Stock Option Grant | −15,000 | 0 | D |
Loading xslF345X03/form4.xml…